SummaryRMgm-5385
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 37327340 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 2.34 |
Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Kuehnel RM, Brochet M |
Name Group/Department | Department of Microbiology and Molecular Medicine, Faculty of Medicine |
Name Institute | University of Geneva |
City | Geneva |
Country | Switzerland |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-5385 |
Principal name | GCα::3xHA |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not tested |
Gametocyte/Gamete | See additional information |
Fertilization and ookinete | Not tested |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation As both PDEα and PDEδ were found to be active at 37°C, we wondered whether simultaneous deletion of both enzymes would lead to premature and abortive activation of gametocytes. A PDEα/δ-KO clonal line (RMgm-5384) did not show any obvious growth defect of asexual blood stages or growth defect in the formation of male and female gametocytes. However, activation of PDEα/δ-KO gametocytes with XA at 20°C did not lead to the formation of active exflagellation centers, and male gametogenesis was found to be blocked at an early stage as no DNA replication could be observed upon stimulation with XA and a rise in pH. Together, these results demonstrate that neither PDEα nor PDEδ directly contribute to the elevation of cGMP levels in response to XA or pH. Instead, both enzymes are active at 37°C to prevent premature activation of gametocytes in the vertebrate host. Simultaneous deletion of PDEα and PDEδ likely leadsto prolonged premature and abortive activation of gametogenesis due to sustained elevated cGMP levels at a non-permissive temperature that leads to an early block between calcium mobilization and DNA replication in microgametocytes. This emphasizes an important and unexpected role of temperature in the efficient progression of DNA replication in microgametocytes. As synthesis of cGMP seems to be a limiting factor in the activation of gametocytes in response to XA or a rise in pH, we turned our attention to the two cGMP-producing GCs. GCβ was previously shown to be redundant for gamete formation. Analysis of a GCβ-disrupted mutant showed no calcium defect in response to XA, or PDE inhibitors in gametocytes both at 20° and 37°C. Consistent with this observation, knocking down GCα in developing gametocytes previously revealed the crucial role of this GC in mediating XA response in P. yoelii. To study the role of GCα in P. berghei gametocytes, an AID/HA tag was added to the GCα C-terminus), which imposed a fitness cost, with low exflagellation rates even in the absence of auxin. However, a 1-hour treatment with auxin of gametocytes before activation led to a further significant reduction in exflagellation and calcium mobilization upon XA, pH, or BIPPO treatments. Calcium response to the calcium ionophore A23187 was however normal, suggesting that the parasite calcium stores are not affected upon GCα-AID/HA depletion. Together, these results confirm that, in gametocytes, GCα is the main GC responsible for basal or induced cGMP synthesis in response to XA or a rise in extracellular pH. |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_0910300 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1138400 | ||||||||||||||||||||||||||
Gene product | guanylyl cyclase alpha | ||||||||||||||||||||||||||
Gene product: Alternative name | GCα | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | triple-HA | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | |||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr/yfcu | ||||||||||||||||||||||||||
Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | The gene deletion–targeting vector for pdeα was constructed using the pAB022 plasmid, which contains polylinker sites flanking an hdhfr expression cassette conferring resistance to pyrimethamine. Polymerase chain reaction (PCR) primers MB763 and MB764 were used to generate a fragment of pdeα 5′ upstream sequence from genomic DNA, which was inserted into Hind III and Pst I restriction sites upstream of the hdhfr cassette. A fragment generated with primers MB765 and MB766 from the 3′ flanking region of pdeα was then inserted downstream of the hdhfr cassette using Kpn I and Not I restriction sites. The linear targeting sequence was released using Hind III and Not I, and the construct was transfected into the ANKA line 2.34 or PDEδ-KO. 3xHA, KO, or AID/HA tagging of GCα, UGO, and PDEγ was generated using phage recombineering in Escherichia coli TSA strain with PlasmoGEM vectors (https://plasmogem.umu.se/pbgem/). For final targeting vectors not available in the PlasmoGEM repository, generation of KO and tagging constructs was performed using sequential recombineering and gateway steps as previously described. For each gene of interest (goi), the Zeocin resistance/Phe sensitivity cassette was introduced using oligonucleotides goi HA-F × goi HA-R and goi KO-F × goi KO-R for 3xHA, AID/HA tagging, and KO targeting vectors. Insertion of the gateway (GW) cassette following gateway reaction was confirmed using primer pairs GW1 × goi QCR1 and GW2 × goi QCR2. The modified library inserts were then released from the plasmid backbone using Not I. The UGO-AID/HA and GCα-AID/HA targeting vectors were transfected into the 615 parasite line, and the PDEγ-KO, UGO-3xHA, and GCα-3xHA vectors into the 2.34 line | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |